NCRT Combined With Sequential Perioperative PD-1 Inhibitor for LAESCC

Summary

This study aims to examine the efficacy of the combination of neoadjuvant chemoradiotherapy and perioperative PD-1 inhibitor in patients with locally advanced esophageal squamous cell cancer and explore the predictive biomarkers for this regimen.

Timeline

Start

2024-10-30

Primary completion

2027-12-01

Completion

2029-12-01

Drugs

Indications